Men diagnosed at this hospital trust can access the following services:

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under general anaesthetic
• Isotope bone scan

• Support Service Facilities:
• Urology CNS

For Wales, this data completeness relates to patients diagnosed between April 2022 and March 2023.
For England, this data completeness relates to patients diagnosed in 2021. This is the data completeness of the National Cancer Registration Dataset (NCRD). For data completeness of the Rapid Cancer Registration Dataset (RCRD), please refer to the NPCA quarterly reports.

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	299	868
Performance Status recorded	27%	41%
PSA completed	80%	64%
Gleason Score completed	77%	46%
TNM completed	60%	58%

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

	Specialist MDT	National
No. of men with disease status determined	675	39897
Percentage of men diagnosed with metastatic disease	17%	17%

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

	Specialist MDT	National
No. of men diagnosed with low-risk localised disease	37	4684
Percentage of men with low-risk localised disease receiving radical treatment	10%	8%
No. of men diagnosed with locally advanced disease	210	15410
Percentage of men diagnosed with locally advanced disease receiving radical treatment	71%	68%